Request Demo
Last update 08 May 2025
BT02
Last update 08 May 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms |
Target |
Action inhibitors |
Mechanism ITPRIPL1 inhibitors(ITPRIP like 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with BT02CTR20240083
评估BT02在晚期实体瘤患者中的安全性、耐受性、药代动力学、免疫原性和初步抗肿瘤活性的开放标签I/II期研究
[Translation] An open-label Phase I/II study evaluating the safety, tolerability, pharmacokinetics, immunogenicity and preliminary anti-tumor activity of BT02 in patients with advanced solid tumors
NCT06404905
A First-in-Human, Open Label, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Antitumor Activity of BT02 in Patients With Advanced Solid Tumors
ChiCTR2300075191
A phase I open dose exploration study to evaluate the safety, tolerability, pharmacokinetic characteristics and anti-tumor efficacy of BT02 in patients with advanced solid tumors
100 Clinical Results associated with BT02
Login to view more data
100 Translational Medicine associated with BT02
Login to view more data
100 Patents (Medical) associated with BT02
Login to view more data
100 Deals associated with BT02
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 25 Jan 2024 | |
| Colorectal Cancer | IND Approval | China | 08 Jan 2024 | |
| Metastatic melanoma | IND Approval | China | 08 Jan 2024 | |
| Non-Small Cell Lung Cancer | IND Approval | China | 08 Jan 2024 | |
| Small Cell Lung Cancer | IND Approval | China | 08 Jan 2024 | |
| Soft Tissue Sarcoma | IND Approval | China | 08 Jan 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free